Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIVIRAL COMPOUND AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/142731
Kind Code:
A1
Abstract:
Disclosed are an antiviral compound and a preparation method therefor. The structural formula of the compound is as represented by formula I. In formula (I), R1 is selected from: monosubstituted or polysubstituted H, F, methyl, and trifluoromethyl; R2 is selected from: H and straight-chain or substituted alkanes (C1-C6); R3 is selected from: monosubstituted or polysubstituted H, Cl, Br, and F. Experiments prove that the compound of the present invention not only has a good inhibition effect on H1N1 influenza A virus, but also has a good inhibition effect on coronavirus. No toxicity to human normal cells is observed, and the degree of an inflammatory response can be inhibited while resisting viruses.

Inventors:
WANG WEI (CN)
LU YONGZHANG (CN)
TAN JINHUI (CN)
Application Number:
PCT/CN2021/128948
Publication Date:
July 07, 2022
Filing Date:
November 05, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGDONG ZHONGKE MEDICINE R&D LTD (CN)
International Classes:
C07D277/50; A61K31/426; A61K31/427; A61K31/454; A61K31/496; A61K31/5377; A61K31/675; A61P11/00; A61P11/02; A61P11/04; A61P31/14; A61P31/16
Foreign References:
CN107459496A2017-12-12
CN107375279A2017-11-24
CN106892878A2017-06-27
CN107382902A2017-11-24
CN108721283A2018-11-02
CN1085212A1994-04-13
CN1496360A2004-05-12
CN113939288A2022-01-14
CN105283181A2016-01-27
Other References:
WENLIN SONG ET AL.: "Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agentsMedChemComm", MEDCHEMCOMM, vol. 7, 13 June 2016 (2016-06-13), XP055625552, DOI: 10.1039/C6MD00179C
"Molecular Pharmaceutics", 31 January 2010, HUNAN NORMAL UNIVERSITY PRESS, China, ISBN: 9787564801144, article CHEN, YUXIANG ET AL.: "Design and Application of Prodrugs", pages: 194 - 197, XP009538049
Download PDF: